Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
They grew up with 'almond moms.' Now, they dread going home for the holidays. - 2Pick Your Favored method of transportation
- 3Photos: Hundreds Gather at Bondi Beach After Deadly Attack
- 4Watch interstellar comet 3I/ATLAS make its closest approach to Earth in free livestream on Dec. 18
- 5The hunt for dark matter: a trivia quiz
- Smuggler who called migrants 'chickens' jailed
- ‘Raising 10 red flags’: Is Israel’s army exhausted?
- 6 Top Computer game Control center
- 'The Real Housewives of Rhode Island' 1st teaser trailer unveiled: Which Bachelor Nation star is part of the cast? And when does it premiere?
- Palestinian leader Abbas says elections only after Gaza war ends
- AfD faction in western Germany ousts councilman for firebrand speech
- 'Euphoria' releases Season 3 trailer, premiere date: Watch Rue and Laurie finally face off
- The Best Computer games for Multiplayer Fun
- Undeniably popular Historical centers: Where Craftsmanship and History Meet
